Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy-Reference-Cited by-同舟云学术

Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy

Published:2016-03 Issue:3 Volume:159 Page:893-900
ISSN:0039-6060
Container-title:Surgery
language:en
Short-container-title:Surgery

Author:

Christians Kathleen K.,Heimler Jonathan W.,George Ben,Ritch Paul S.,Erickson Beth A.,Johnston Fabian,Tolat Parag P.,Foley William D.,Evans Douglas B.,Tsai Susan

Publisher

Elsevier BV

Subject

Surgery

Reference31 articles.

1. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement;Callery;Ann Surg Oncol,2009

2. Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement;Evans;Ann Surg Oncol,2009

3. National Comprehensive Cancer Network. NCCN practice guidelines for pancreatic cancer, version 2. Available from: http://www.nccn.org/professionals/physician_gls/recently_updated.asp.

4. Current Staging System for Pancreatic Cancer;Appel;Cancer J,2012

5. Neoadjuvant therapy in pancreatic cancer: an emerging strategy;Bittoni;Gastroenterol Res Pract,2014

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disparities in neoadjuvant chemotherapy for pancreatic adenocarcinoma with vascular involvement;Surgery Open Science;2024-08

2. Determination of “borderline resectable” pancreatic cancer – A global assessment of 30 shades of grey;HPB;2023-11

3. Survival and Late Morbidity after Resection of Pancreatic Cancer;The Pancreas;2023-08-04

4. Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected Pancreatic Ductal Adenocarcinomas;Annals of Surgical Oncology;2023-06-11

5. Utilization of a novel 3D radiologic scoring method to define therapeutic response and surgical candidacy;Frontiers in Imaging;2023-03-29